T. Shirota

Oncolytic herpes virus induces effective anti-cancer immunity against murine colon cancer.

Y. Nishikawa, S. Yamada, T. Fujii, 2011, Hepato-gastroenterology.

Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancer

H. Sugimoto, S. Nomoto, A. Nakao, 2008, Cancer Chemotherapy and Pharmacology.

A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer

S. Yamada, T. Fujii, H. Sugimoto, 2011, Cancer Gene Therapy.

Oncolytic virus therapy against pancreatic cancer

Y. Nishikawa, S. Yamada, T. Fujii, 2010 .

Considerations for intravascular administration of oncolytic herpes virus for the treatment of multiple liver metastases

H. Sugimoto, S. Nomoto, A. Nakao, 2008, Cancer Chemotherapy and Pharmacology.

High therapeutic potential for systemic delivery of a liposome-conjugated herpes simplex virus.

Y. Nishikawa, S. Yamada, T. Fujii, 2011, Current cancer drug targets.

Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes

Y. Nishikawa, S. Yamada, T. Fujii, 2012, Cancer Gene Therapy.